CORBF (Global Cord Blood) Retained Earnings: $455.1 Mil (As of Mar. 2022)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CORBF Global Cord Blood Corp CORBF
12 GF Score
Price $0.95
View Full Analysis

What is Global Cord Blood Retained Earnings?

Global Cord Blood CORBF 12 Retained Earnings is $455.1 Mil as of Mar. 2022. GuruFocus rates CORBF with a GF Score™ of 12/100.

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Global Cord Blood's retained earnings for the quarter that ended in Mar. 2022 was $455.1 Mil.

Global Cord Blood's quarterly retained earnings increased from Sep. 2021 ($410.2 Mil) to Dec. 2021 ($436.9 Mil) and increased from Dec. 2021 ($436.9 Mil) to Mar. 2022 ($455.1 Mil).

Global Cord Blood's annual retained earnings increased from Mar. 2020 ($267.5 Mil) to Mar. 2021 ($366.5 Mil) and increased from Mar. 2021 ($366.5 Mil) to Mar. 2022 ($455.1 Mil).


Global Cord Blood  (OTCPK:CORBF) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


Global Cord Blood Retained Earnings Historical Data

* Premium members only.

The historical data trend for Global Cord Blood's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Global Cord Blood Retained Earnings Chart

Global Cord Blood Annual Data
Trend Mar13 Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22
Retained Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 176.79 209.66 267.49 366.49 455.07

Global Cord Blood Quarterly Data
Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22
Retained Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 366.49 392.62 410.20 436.87 455.07
CORBF
12GF Score
Global Cord Blood Corp CORBF
Retained Earnings is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Global Cord Blood Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Frequently Asked Questions Learn more about Retained Earnings →
What does a Retained Earnings of $455.1 Mil mean?
Global Cord Blood (CORBF) has a Retained Earnings of $455.1 Mil as of Mar. 2022. Retained earnings is the amount of net income not issued to shareholders. View historical data on Global Cord Blood and its competitors.
Is Global Cord Blood's Retained Earnings too high?
Global Cord Blood's current Retained Earnings is $455.1 Mil. Overall, Global Cord Blood has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Global Cord Blood's Retained Earnings compare to PRE and LMDX?
Global Cord Blood's Retained Earnings of $455.1 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Retained Earnings for a Medical Diagnostics & Research company?
A good Retained Earnings depends on the Medical Diagnostics & Research industry context. However, Retained Earnings should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Retained Earnings mean?
A high Retained Earnings can signal that a stock is expensive relative to its fundamentals. Retained earnings is the amount of net income not issued to shareholders. View historical data on Global Cord Blood and its competitors. Global Cord Blood's current Retained Earnings is $455.1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Global Cord Blood stock overvalued right now?
Global Cord Blood (CORBF) has a current Retained Earnings of $455.1 Mil. The current Retained Earnings is $455.1 Mil. Global Cord Blood's overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Retained Earnings calculated?
Retained Earnings is calculated from a company's financial statements. For Global Cord Blood (CORBF), the current Retained Earnings is $455.1 Mil as of Mar. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Global Cord Blood Business Description

Address 1 Garden Road, 48th Floor, Bank of China Tower, Central, Hong Kong, HKG
Global Cord Blood Corp provides cord blood banking services. The company provides cord blood processing and storage services for expectant parents interested in capturing the evolving medical treatments and technologies such as cord blood transplants. The company generates all of its revenues by providing subscribers with processing services, which consist of the testing and processing of cord blood units, and storage services, which consist of the storage of cord blood units in its facilities.
12GF Score

Get the complete analysis for CORBF

Retained Earnings is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.95
Price